Cargando…
In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387467/ https://www.ncbi.nlm.nih.gov/pubmed/35490771 http://dx.doi.org/10.1016/j.bjid.2022.102355 |
| _version_ | 1784770023683784704 |
|---|---|
| author | Cuba, Gabriel T. Santos, Paulo H.D. Pignatari, Antonio C.C. Nicolau, David P. Kiffer, Carlos R.V. |
| author_facet | Cuba, Gabriel T. Santos, Paulo H.D. Pignatari, Antonio C.C. Nicolau, David P. Kiffer, Carlos R.V. |
| author_sort | Cuba, Gabriel T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9387467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93874672022-08-23 In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy? Cuba, Gabriel T. Santos, Paulo H.D. Pignatari, Antonio C.C. Nicolau, David P. Kiffer, Carlos R.V. Braz J Infect Dis Letter to the Editor Elsevier 2022-04-28 /pmc/articles/PMC9387467/ /pubmed/35490771 http://dx.doi.org/10.1016/j.bjid.2022.102355 Text en © 2022 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Letter to the Editor Cuba, Gabriel T. Santos, Paulo H.D. Pignatari, Antonio C.C. Nicolau, David P. Kiffer, Carlos R.V. In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy? |
| title | In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy? |
| title_full | In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy? |
| title_fullStr | In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy? |
| title_full_unstemmed | In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy? |
| title_short | In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy? |
| title_sort | in vitro potency of amikacin against carbapenem-resistant pseudomonas aeruginosa: a target for nebulization strategy? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387467/ https://www.ncbi.nlm.nih.gov/pubmed/35490771 http://dx.doi.org/10.1016/j.bjid.2022.102355 |
| work_keys_str_mv | AT cubagabrielt invitropotencyofamikacinagainstcarbapenemresistantpseudomonasaeruginosaatargetfornebulizationstrategy AT santospaulohd invitropotencyofamikacinagainstcarbapenemresistantpseudomonasaeruginosaatargetfornebulizationstrategy AT pignatariantoniocc invitropotencyofamikacinagainstcarbapenemresistantpseudomonasaeruginosaatargetfornebulizationstrategy AT nicolaudavidp invitropotencyofamikacinagainstcarbapenemresistantpseudomonasaeruginosaatargetfornebulizationstrategy AT kiffercarlosrv invitropotencyofamikacinagainstcarbapenemresistantpseudomonasaeruginosaatargetfornebulizationstrategy |